The Antimicrobial Resistance (AMR) Diagnostics market is segmented By Technology (Microbiology Culture, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Mass Spectrometry, Rapid and Point-of-Care Testing), By Pathogen (Methicillin-Resistant Staphylococcus aureus (MRSA), Drug-Resistant Streptococcus pneumoniae, Clostridium difficile, Drug-Resistant Neisseria gonorrhoeae, Drug-Resistant Salmonella, Other Emerging Resistant Pathogens), and By End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutes).
20% Free Customization ON ALL PURCHASE
*Terms & Conditions Apply